As these studies demonstrate, correction of the LAMP2 mutation resulted in increases in ATP production, oxygen consumption rate, and maximum respiratory rate, all of which are comparable to normal in vitro, indicating that this correction may improve the partial phenotype of Danon disease and reveal potential targets for therapeutic intervention. This evidence concerns the gene LAMP2 and Danon disease.